NEW YORK–(BUSINESS WIRE)–$PIPR—Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Brandon Rice as a managing director within the healthcare investment banking group. Rice joins Piper Sandler with 17 years of healthcare investment banking experience in strategic and capital markets transactions across the med-tech sector. Rice will continue to cover the med-tech sector and will be based in the firm’s New York office.
“Brandon brings high-profile relationships and extensive transaction experience in the med-tech sector to our team. The addition of Brandon’s expertise positions us for continued market leadership advising med-tech companies and ensures we continue to deliver best-in-class services to our clients. We are excited to welcome him to the healthcare team,” said J.P. Peltier, global group head of healthcare investment banking.
Prior to joining the firm, Rice spent 17 years at Bank of America Securities, most recently as a managing director in the global healthcare investment banking group. In this role, his primary focus was M&A advisory and capital raising for both public and private disruptive medical technology companies. He began his career at Merrill Lynch in 2006, prior to its merger with Bank of America Securities.
“Piper Sandler has been the trusted partner in medical devices for several decades, with a long history of leadership in M&A and capital raising. I am thrilled to be joining a franchise that shares my deep commitment to entrepreneurs and companies that are driving meaningful innovation and disruption in medical devices and the broader healthcare sector,” said Rice.
ABOUT PIPER SANDLER
Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.
Follow Piper Sandler: LinkedIn | Facebook | X
©2023. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036
Contacts
Pamela Steensland
Tel: 612 303-8185
pamela.steensland@psc.com
NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…
DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…
Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…
Diarrhea is one of the most common reasons for veterinary visits for dogs and the…
Developing innovative bispecific antibodies for monotherapy and combination with the potential to expand the frontiers…
FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the…